Skip to content

Insider · CIK 0001648746

Spiro C. Lazarakis

director

Files at DGII (DIGI INTERNATIONAL INC). First filing -, latest -.

Spiro C. Lazarakis files SEC Form 4 as director at DGII (DIGI INTERNATIONAL INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Spiro C. Lazarakis has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 9, 2026DGII
DIGI INTERNATIONAL INC
AGrant or award
Common Stock
+4,066$0.00$083,010Feb 11, 2026
Feb 10, 2025DGII
DIGI INTERNATIONAL INC
AGrant or award
Common Stock
+3,977$0.00$078,944Feb 12, 2025

Questions about Spiro C. Lazarakis

Answered from the filings on this page, as of the latest one.

Is Spiro C. Lazarakis buying or selling?

Spiro C. Lazarakis has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Spiro C. Lazarakis's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Spiro C. Lazarakis has 0.

Where does Spiro C. Lazarakis file Form 4?

Spiro C. Lazarakis has filed Form 4 at DGII (DIGI INTERNATIONAL INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.